Apply now for the 2027 Leadership Academy cohort! Nominations are open through Nov. 9, 2026. | LEARN MORE

JOM

Cervical cancer screening among women with comorbidities: a cross-sectional examination of disparities from the Behavioral Risk Factor Surveillance System

By JOM Staff

08.02.22

Implementation of guideline-based Papanicolaou (Pap) smear screening, human papillomavirus (HPV) testing, and HPV vaccination has reduced cervical cancer (CC) rates up to 80%, yet prevention disparities continue to exist.